College of Life Sciences, Northwest University, Xi'an 710069, China.
Anal Chem. 2022 Jun 28;94(25):9048-9057. doi: 10.1021/acs.analchem.2c01210. Epub 2022 Jun 13.
Allosteric ligands are promising drugs owing to their remote regulations of the orthosteric ligand signaling pathway. There are few allosteric ligands due to the lack of handy and efficacious method for the screening. Herein, we developed an affinity chromatographic method for allosteric ligand screening by immobilizing purified beta2 adrenoceptor (β-AR) onto macroporous silica gel by a two-point tethering method. The method relies on the occupation of the orthosteric site by an antagonist and the chelation of N-terminal His-tag of the receptor and Ni coated on the gel. The immobilized β-AR demonstrated the greatest allosteric responsive feature when Cmpd-15 (0.25 μM) was included in the mobile phase. Under the same conditions, the association constants of three agonists (salbutamol, terbutaline, and tulobuterol) reduced to 47%, 19%, and 27% compared with the data without the inclusion of Cmpd-15 in the mobile phase. APF was screened as a potential allosteric modulator of β-AR by applying the immobilized receptor in a natural product-derived DNA-encoded chemical library (DEL). Relying on these results, we reasoned that the current method has potential in screening allosteric ligands of the receptor. We expect that it is applicable for the discovery of new allosteric binding sites of a target protein and screening allosteric modulators of the other receptors from complex samples.
变构配体因其对正位配体信号通路的远程调节而成为有前途的药物。由于缺乏简便有效的筛选方法,因此变构配体的数量很少。在此,我们通过两点连接法将纯化的β2 肾上腺素受体(β-AR)固定在大孔硅胶上,开发了一种用于变构配体筛选的亲和色谱方法。该方法依赖于拮抗剂占据正位点以及受体 N 端 His 标签和 Ni 的螯合固定在凝胶上。当在流动相中包含 Cmpd-15(0.25 μM)时,固定化的β-AR 表现出最大的变构反应特征。在相同条件下,与不包含 Cmpd-15 的流动相相比,三种激动剂(沙丁胺醇、特布他林和妥布特罗)的结合常数降低至 47%、19%和 27%。APF 通过将固定化受体应用于天然产物衍生的 DNA 编码化学文库(DEL)中被筛选为β-AR 的潜在变构调节剂。基于这些结果,我们推断当前的方法有可能筛选受体的变构配体。我们期望它适用于发现靶蛋白的新变构结合位点和从复杂样品中筛选其他受体的变构调节剂。